Treating Tumors at Low Drug Doses Using an Aptamer-Peptide Synergistic Drug Conjugate …………… Pusuluri A, Krishnan V, Lensch V, Sarode A, Bunyan E, Vogus DR, Menegatti S, Soh HT, Mitragotri S. Angew Chem Int Ed Engl. 2019 Jan 28;58(5):1437-1441. PubMed 00
Bioinspired Engineering of a Multivalent Aptamer-Functionalized Nanointerface to Enhance the Capture and Release of Circulating Tumor Cells …………… Song Y, Shi Y, Huang M, Wang W, Wang Y, Cheng J, Lei Z, Zhu Z, Yang C. Angew Chem Int Ed Engl. 2018 Dec 13. PubMed 00
Poly-Target Selection Identifies Broad-Spectrum RNA Aptamers …………… Alam KK, Chang JL, Lange MJ, Nguyen PDM, Sawyer AW, Burke DH. Mol Ther Nucleic Acids. 2018 Dec 7;13:605-619. PubMed 00
Phosphorothioate-Modified AP613-1 Specifically Targets GPC3 when Used for Hepatocellular Carcinoma Cell Imaging …………… Dong L, Zhou H, Zhao M, Gao X, Liu Y, Liu D, Guo W, Hu H, Xie Q, Fan J, Lin J, Wu W. Mol Ther Nucleic Acids. 2018 Dec 7;13:376-386. PubMed 00